Skip to main content

Quantification of Free Phenytoin by Liquid Chromatography Tandem Mass Spectrometry (LC/MS/MS)

  • Protocol
Clinical Applications of Mass Spectrometry in Drug Analysis

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1383))

Abstract

Phenytoin (diphenylhydantoin) is an anticonvulsant drug that has been used for decades for the treatment of many types of seizures. The drug is highly protein bound and measurement of free-active form of the drug is warranted particularly in patients with conditions that can affect drug protein binding. Here, we describe a LC/MS/MS method for the measurement of free phenytoin. Free drug is separated by ultrafiltration of serum or plasma. Ultrafiltrate is treated with acetonitrile containing internal standard phenytoin d-10 to precipitate proteins. The mixture is centrifuged and supernatant is injected onto LC-MS-MS, and analyzed using multiple reaction monitoring. This method is linear from 0.1 to 4.0 μg/mL and does not demonstrate any significant ion suppression or enhancement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Broussard LA (2007) Monitoring anticonvulsants concentrations: general considerations. In: Hammett-Stabler CA, Dasgupta A (eds) Therapeutic drug monitoring data. AACC Press, Washington, D.C., pp 41–75

    Google Scholar 

  2. Moyer TP, Shaw LM (2006) Therapeutic drugs and their management. In: Burtis CA, Ashwood ER, Bruns DE (eds) Tietz textbook of clinical chemistry and molecular diagnostics, 4th edn. Elsevier Saunders, St. Louis, MO, pp 1237–1285

    Google Scholar 

  3. Biddle DA, Wells A, Dasgupta A (2000) Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALDI mass spectrometric determination of molecular weight range of inhibitors. Life Sci 66:143–151

    Article  CAS  PubMed  Google Scholar 

  4. Wolf GK, McClain CD, Zurakowski D, Dodson B, McManus ML (2006) Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children. Pediatr Crit Care Med 7:434–439, quiz 440

    Article  PubMed  Google Scholar 

  5. Bardin S, Ottinger JC, Breau AP, O’Shea TJ (2000) Determination of free levels of phenytoin in human plasma by liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal 23:573–579

    Article  CAS  PubMed  Google Scholar 

  6. Godolphin W, Trepanier J (1984) Gas chromatography versus immunoassay (EMIT) for analysis of free phenytoin in serum ultrafiltrate. Ther Drug Monit 6:374–375

    Article  CAS  PubMed  Google Scholar 

  7. Joern WA (1981) Gas-chromatographic assay of free phenytoin in ultrafiltrates of plasma: test of a new filtration apparatus and specimen stability. Clin Chem 27:417–421

    CAS  PubMed  Google Scholar 

  8. Lin PC, Hsieh YH, Liao FF, Chen SH (2010) Determination of free and total levels of phenytoin in human plasma from patients with epilepsy by MEKC: an adequate alternative to HPLC. Electrophoresis 31:1572–1582

    CAS  PubMed  Google Scholar 

  9. May T, Rambeck B (1990) Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication. Ther Drug Monit 12:124–128

    Article  CAS  PubMed  Google Scholar 

  10. Van Langenhove A, Costello CE, Biller JE, Biemann K, Browne TR (1980) A mass spectrometric method for the determination of stable isotope labeled phenytoin suitable for pulse dosing studies. Biomed Mass Spectrom 7:576–581

    Article  PubMed  Google Scholar 

  11. Van Langenhove A, Costello CE, Biller JE, Biemann K, Browne TR (1981) A gas chromatographic/mass spectrometric method for the simultaneous quantitation of 5,5-diphenylhydantoin (phenytoin), its para-hydroxylated metabolite and their stable isotope labelled analogs. Clin Chim Acta 115:263–275

    Article  PubMed  Google Scholar 

  12. Garg U, Peat J, Frazee C 3rd, Nguyen T, Ferguson AM (2013) A simple isotope dilution electrospray ionization tandem mass spectrometry method for the determination of free phenytoin. Ther Drug Monit 35:831–835

    Article  CAS  PubMed  Google Scholar 

  13. Datta P (1997) Oxaprozin and 5-(p-hydroxyphenyl)-5-phenylhydantoin interference in phenytoin immunoassays. Clin Chem 43:1468–1469

    CAS  PubMed  Google Scholar 

  14. Datta P, Scurlock D, Dasgupta A (2005) Analytic performance evaluation of a new turbidimetric immunoassay for phenytoin on the ADVIA 1650 analyzer: effect of phenytoin metabolite and analogue. Ther Drug Monit 27:305–308

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uttam Garg .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Peat, J., Frazee, C., Garg, U. (2016). Quantification of Free Phenytoin by Liquid Chromatography Tandem Mass Spectrometry (LC/MS/MS). In: Garg, U. (eds) Clinical Applications of Mass Spectrometry in Drug Analysis. Methods in Molecular Biology, vol 1383. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3252-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3252-8_25

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3251-1

  • Online ISBN: 978-1-4939-3252-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics